Belgium, March 17, 2023 – Synergia Medical, a preclinical medical device company that has developed NAO.VNS, the first optoelectronic neurostimulator for the treatment of drug-resistant epilepsy through Vagus Nerve Stimulation, is pleased to announce that they have been awarded the Prix Galien 2023 in Belgium for promising medical devices.
"I am delighted for all the team at Synergia Medical to have won this prestigious and world-renowned award. The recognition by the jury that our device has the potential to bring a breakthrough treatment to the many epilepsy patients who live in the constant fear of an epileptic seizure is extremely encouraging. It is a great honour to receive this award soon after being selected by the European Union EIC Accelerator program.” declared Attila Borbath, CEO & Co-founder of Synergia Medical. “On the operational front, we recently completed our pre-clinical safety study successfully with very promising results. We are now focused on preparing our First-In-Human study, scheduled next year, and our FDA filing in the US.” he added.
About The Prix Galien
The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research. The Prix Galien in Belgium is organised by “Le Journal du Médecin.”